Systematic molecular and cytogenetic screening of 100 patients with marfanoid syndromes and intellectual disability

The association of marfanoid habitus (MH) and intellectual disability (ID) has been reported in the literature, with overlapping presentations and genetic heterogeneity. A hundred patients (71 males and 29 females) with a MH and ID were recruited. Custom‐designed 244K array‐CGH (Agilent®; Agilent Technologies Inc., Santa Clara, CA) and MED12, ZDHHC9, UPF3B, FBN1, TGFBR1 and TGFBR2 sequencing analyses were performed. Eighty patients could be classified as isolated MH and ID: 12 chromosomal imbalances, 1 FBN1 mutation and 1 possibly pathogenic MED12 mutation were found (17%). Twenty patients could be classified as ID with other extra‐skeletal features of the Marfan syndrome (MFS) spectrum: 4 pathogenic FBN1 mutations and 4 chromosomal imbalances were found (2 patients with both FBN1 mutation and chromosomal rearrangement) (29%). These results suggest either that there are more loci with genes yet to be discovered or that MH can also be a relatively non‐specific feature of patients with ID. The search for aortic complications is mandatory even if MH is associated with ID since FBN1 mutations or rearrangements were found in some patients. The excess of males is in favour of the involvement of other X‐linked genes. Although it was impossible to make a diagnosis in 80% of patients, these results will improve genetic counselling in families.

C Binquet | A. Mégarbané | A. Toutain | N. Philip | G. Jondeau | P. Jouk | D. Lacombe | L. Pasquier | E. Colin | J. Thevenon | G. Collod-Béroud | S. Lyonnet | L. Faivre | C. Baumann | C. Thauvin-Robinet | C. Boileau | Pierre Vabres | C. Goizet | B. Aral | V. Cormier-Daire | P. Callier | J. Amiel | C. Binquet | F. Huet | A. Jacquette | S. Odent | C. Coubes | M. Doco‐Fenzy | D. Heron | H. Journel | C. Francannet | Y. Dulac | A. Goldenberg | M. Delrue | M. Addor | G. Plessis | N. Marle | B. Leheup | Y. Sznajer | F. Mugneret | D. Martin‐Coignard | P. Sarda | C Boileau | V. Carmignac | V Cormier-Daire | S Lyonnet | J Amiel | D Heron | P S Jouk | G Jondeau | S. Julia | A. Mosca-Boidron | M. Payet | C. Ragon | N Philip | L Faivre | G Collod-Beroud | P Khau Van Kien | P Callier | B Aral | N Hanna | S Lambert | H Dindy | C Ragon | M Payet | V Carmignac | M A Delrue | C Goizet | T Busa | Y Dulac | I Missotte | Y Sznajer | A Toutain | C Francannet | A Megarbane | S Julia | T Edouard | P Sarda | B Gilbert | A Jacquette | P Collignon | D Lacombe | F Morice-Picard | V Cusin | M Willems | E Sarrazin | K Amarof | C Coubes | M C Addor | H Journel | E Colin | C Baumann | B Leheup | D Martin-Coignard | M Doco-Fenzy | A Goldenberg | G Plessis | J Thevenon | L Pasquier | S Odent | P Vabres | F Huet | N Marle | A L Mosca-Boidron | F Mugneret | S Gauthier | C Thauvin-Robinet | S. Gauthier | N. Hanna | E. Sarrazin | P. Khau Van Kien | M. Willems | B. Gilbert | V. Cusin | T. Edouard | P. Collignon | T. Busa | I. Missotte | F. Morice-Picard | S. Lambert | H. Dindy | K. Amarof

[1]  Wolfram Kress,et al.  A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2 , 2005, Nature Genetics.

[2]  S. Knuutila,et al.  19p13.3 Aberrations Are Associated with Dysmorphic Features and Deviant Psychomotor Development , 2010, Cytogenetic and Genome Research.

[3]  H. Dietz,et al.  Mutation in fibrillin-1 and the Marfanoid-craniosynostosis (Shprintzen-Goldberg) syndrome , 1996, Nature Genetics.

[4]  R. Kosaki,et al.  Molecular pathology of Shprintzen–Goldberg syndrome , 2006, American journal of medical genetics. Part A.

[5]  C. Béroud,et al.  A new locus‐specific database (LSDB) for mutations in the TGFBR2 gene: UMD‐TGFBR2 , 2008, Human mutation.

[6]  R E Pyeritz,et al.  Revised diagnostic criteria for the Marfan syndrome. , 1996, American journal of medical genetics.

[7]  D. Milewicz,et al.  A mutation in FBN1 disrupts profibrillin processing and results in isolated skeletal features of the Marfan syndrome. , 1995, The Journal of clinical investigation.

[8]  J. Fryns,et al.  X-linked mental retardation with Marfanoid habitus: a changing phenotype with age? , 1991, Genetic counseling.

[9]  Gabor Matyas,et al.  Update of the UMD‐FBN1 mutation database and creation of an FBN1 polymorphism database , 2003, Human mutation.

[10]  C. Magri,et al.  De novo deletion of chromosome 2q24.2 region in a mentally retarded boy with muscular hypotonia. , 2011, European journal of medical genetics.

[11]  M. Williams,et al.  Aortic root dilation in apparent Lujan-Fryns syndrome. , 1999, American journal of medical genetics.

[12]  L. Tavazzi,et al.  Identification of sixty‐two novel and twelve known FBN1 mutations in eighty‐one unrelated probands with Marfan syndrome and other fibrillinopathies , 2005, Human mutation.

[13]  Andrew Menzies,et al.  Mutations in ZDHHC9, which encodes a palmitoyltransferase of NRAS and HRAS, cause X-linked mental retardation associated with a Marfanoid habitus. , 2007, American journal of human genetics.

[14]  G. Pals,et al.  Compound-heterozygous Marfan syndrome. , 2009, European journal of medical genetics.

[15]  Sjzhong Zhang,et al.  5p;12q translocation with manifestations of cri du chat syndrome and Marfanoid arachnodactyly , 1990, Clinical genetics.

[16]  J. Opitz,et al.  A recurrent mutation in MED12 leading to R961W causes Opitz-Kaveggia syndrome , 2007, Nature Genetics.

[17]  B. Chevallier,et al.  Syndrome de Marfan : critères diagnostiques et apport de la biologie moléculaire , 2008 .

[18]  H. Lubs,et al.  A form of X-linked mental retardation with marfanoid habitus. , 1984, American journal of medical genetics.

[19]  J. Mosser,et al.  Clinical and molecular characterization of 17q21.31 microdeletion syndrome in 14 French patients with mental retardation. , 2011, European journal of medical genetics.

[20]  A. De Paepe,et al.  Cytogenetic and array‐CGH characterization of a 6q27 deletion in a patient with developmental delay and features of Ehlers–Danlos syndrome , 2010, American journal of medical genetics. Part A.

[21]  J. Vermeesch,et al.  Mosaicism for duplication 12q (12q13→12q21.2) accompanied by a pericentric inversion in a dysmorphic female infant , 2002, Journal of medical genetics.

[22]  J. Harvey,et al.  Application of dHPLC for mutation detection of the fibrillin-1 gene for the diagnosis of Marfan syndrome in a National Health Service Laboratory. , 2007, Genetic testing.

[23]  E. Conti,et al.  Nonsense-mediated mRNA decay: molecular insights and mechanistic variations across species. , 2005, Current opinion in cell biology.

[24]  P. Robinson,et al.  Shprintzen–Goldberg syndrome: Fourteen new patients and a clinical analysis , 2005, American journal of medical genetics. Part A.

[25]  Yu Wang,et al.  A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures , 2008, Nature Genetics.

[26]  Marjo-Riitta Järvelin,et al.  Temporal changes in incidence and prevalence of intellectual disability between two birth cohorts in Northern Finland. , 2003, American journal of mental retardation : AJMR.

[27]  F. López-Muñoz,et al.  Psychopathology in the Lujan–Fryns syndrome: Report of two patients and review , 2006, American journal of medical genetics. Part A.

[28]  F. Flinter,et al.  Terminal deletion of chromosome 5p in a patient with phenotypical features of Lujan–Fryns syndrome , 2003, American journal of medical genetics. Part A.

[29]  A. Child,et al.  Erratum: Detection of six novel FBN1 mutations in British patients affected by Marfan syndrome , 2001, Human mutation.

[30]  M. V. van Steensel,et al.  Shprintzen‐Goldberg syndrome associated with a novel missense mutation in TGFBR2 , 2008, Experimental dermatology.

[31]  J. Gécz,et al.  Mutations in UPF3B, a member of the nonsense-mediated mRNA decay complex, cause syndromic and nonsyndromic mental retardation , 2007, Nature Genetics.

[32]  Laurence Faivre,et al.  The revised Ghent nosology for the Marfan syndrome , 2010, Journal of Medical Genetics.

[33]  R. Shprintzen,et al.  Shprintzen-Goldberg syndrome: a clinical analysis. , 1998, American journal of medical genetics.

[34]  M. Stratton,et al.  The original Lujan syndrome family has a novel missense mutation (p.N1007S) in the MED12 gene , 2007, Journal of Medical Genetics.

[35]  P. Elliott,et al.  Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus , 2011, Nature.

[36]  Christophe Béroud,et al.  UMD‐predictor, a new prediction tool for nucleotide substitution pathogenicity—application to four genes: FBN1, FBN2, TGFBR1, and TGFBR2 , 2009, Human mutation.

[37]  G. Neri,et al.  A girl with the Lujan-Fryns syndrome. , 1991, American journal of medical genetics.

[38]  B. D. de Vries,et al.  3q29 microdeletion syndrome: clinical and molecular characterization of a new syndrome. , 2005, American journal of human genetics.

[39]  Glen Brice,et al.  The importance of mutation detection in Marfan syndrome and Marfan‐related disorders: report of 193 FBN1 mutations , 2007, Human mutation.

[40]  E. Haan,et al.  FBN1, TGFBR1, and the Marfan‐craniosynostosis/mental retardation disorders revisited , 2006, American journal of medical genetics. Part A.

[41]  H. Zoghbi,et al.  Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. , 1992, American journal of human genetics.

[42]  D. Creamer,et al.  A diagnostic challenge: acute generalized exanthematous pustulosis or pustular psoriasis due to terbinafine: comment , 2012, Clinical and experimental dermatology.

[43]  E. Arbustini,et al.  The new Ghent criteria for Marfan syndrome: what do they change? , 2012, Clinical genetics.

[44]  R. Deschenes,et al.  DHHC9 and GCP16 Constitute a Human Protein Fatty Acyltransferase with Specificity for H- and N-Ras* , 2005, Journal of Biological Chemistry.

[45]  R. Tervo,et al.  Expanding the clinical phenotype of the 3q29 microdeletion syndrome and characterization of the reciprocal microduplication , 2008, Molecular Cytogenetics.

[46]  E. Arbustini,et al.  Pathogenic FBN1 mutations in 146 adults not meeting clinical diagnostic criteria for Marfan syndrome: Further delineation of type 1 fibrillinopathies and focus on patients with an isolated major criterion , 2009, American journal of medical genetics. Part A.

[47]  Ton Feuth,et al.  Diagnostic genome profiling in mental retardation. , 2005, American journal of human genetics.

[48]  M Claustres,et al.  Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. , 2007, American journal of human genetics.

[49]  A. Mégarbané,et al.  Severe mental retardation with marfanoid habitus in a young Lebanese male. A diagnostic challenge. , 1997, Genetic counseling.

[50]  C. Junien,et al.  Identification of 23 TGFBR2 and 6 TGFBR1 gene mutations and genotype‐phenotype investigations in 457 patients with Marfan syndrome type I and II, Loeys‐Dietz syndrome and related disorders , 2008, Human mutation.

[51]  E. Arbustini,et al.  Contribution of molecular analyses in diagnosing Marfan syndrome and type I fibrillinopathies: an international study of 1009 probands , 2008, Journal of Medical Genetics.

[52]  M. Meisterernst,et al.  The Mediator of RNA polymerase II , 2005, Chromosoma.

[53]  Bruce Bennetts,et al.  Detection of thirty novel FBN1 mutations in patients with Marfan syndrome or a related fibrillinopathy , 2004, Human mutation.

[54]  K. Gervin,et al.  Rapid and efficient FBN1 mutation detection using automated sample preparation and direct sequencing as the primary strategy. , 2006, Genetic testing.

[55]  M. Holder,et al.  Delineation of 15q13.3 microdeletions , 2010, Clinical genetics.

[56]  M. Tzetis,et al.  De novo interstitial duplication of the 15q11.2‐q14 PWS/AS region of maternal origin: Clinical description, array CGH analysis, and review of the literature , 2010, American journal of medical genetics. Part A.

[57]  J. Fryns,et al.  X-linked mental retardation with marfanoid habitus. , 1987, American journal of medical genetics.

[58]  P. Stankiewicz,et al.  Clinical spectrum associated with recurrent genomic rearrangements in chromosome 17q12 , 2010, European Journal of Human Genetics.

[59]  P. Robinson,et al.  Clinical and Molecular Study of 320 Children With Marfan Syndrome and Related Type I Fibrillinopathies in a Series of 1009 Probands With Pathogenic FBN1 Mutations , 2009, Pediatrics.

[60]  B. Chevallier,et al.  [Marfan syndrome: diagnostic criteria and molecular biology contribution]. , 2008, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[61]  Jean-Pierre Fryns,et al.  Lujan-Fryns syndrome (mental retardation, X-linked, marfanoid habitus) , 2006, Orphanet Journal of Rare Diseases.

[62]  Sung-Kook Hong,et al.  The zebrafish kohtalo/trap230 gene is required for the development of the brain, neural crest, and pronephric kidney. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[63]  C. Béroud,et al.  Human Splicing Finder: an online bioinformatics tool to predict splicing signals , 2009, Nucleic acids research.

[64]  T. Wassink,et al.  Polymorphism analysis of HOPA: A candidate gene for schizophrenia , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[65]  V. Dulieu,et al.  De novo 15q21.1q21.2 deletion identified through FBN1 MLPA and refined by 244K array-CGH in a female teenager with incomplete Marfan syndrome. , 2010, European journal of medical genetics.

[66]  E. Arbustini,et al.  The FBN1 (R2726W) mutation is not fully penetrant , 2004, Annals of human genetics.